Harpoon Therapeutics Inc (HARP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HARP | ZTS | TAK | UTHR | NBIX |
| Company | Harpoon Therapeutics Inc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | United Therapeutic | Neurocrine Bioscienc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 23.00 | 150.97 | 13.15 | 236.83 | 139.37 |
| High | 23.02 | 153.59 | 13.19 | 238.19 | 139.37 |
| Low | 22.99 | 150.04 | 13.05 | 234.33 | 136.06 |
| Last | 23.01 | 153.36 | 13.07 | 235.95 | 137.76 |
| Change | +0.02 | +2.48 | -0.16 | -1.05 | -1.21 |
| % Change | +0.09% | +1.64% | -1.21% | -0.44% | -0.87% |
| Volume | 6,624,300 | 4,567,100 | 1,697,100 | 391,800 | 735,700 |
| 20-Day Average Volume | 1,788,445 | 4,188,745 | 1,762,665 | 528,730 | 792,185 |
| Previous Close | 22.99 | 150.88 | 13.23 | 237.00 | 138.97 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 22.76 | 157.90 | 13.43 | 234.27 | 136.56 |
| 20-Day Raw Stochastic | 77.53% | 32.50% | 2.20% | 65.43% | 51.31% |
| 20-Day Relative Strength | 80.05% | 37.68% | 33.91% | 52.04% | 52.08% |
| Weighted Alpha | +102.30 | -18.25 | -21.99 | +4.42 | +38.02 |
| Today's Opinion | 100% Buy | 88% Sell | 100% Sell | 80% Buy | 96% Buy |
| Previous Opinion | 100% Buy | 88% Sell | 100% Sell | 80% Buy | 96% Buy |
| Last Month's Opinion | 88% Buy | 40% Sell | 56% Sell | 40% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.31% since 03/01/24 | +0.16% since 04/18/24 | -0.68% since 04/18/24 | -0.41% since 04/18/24 | +3.94% since 04/18/24 |
| Low | 22.95 on 03/04/24 | 144.80 on 04/22/24 | 13.05 on 04/25/24 | 233.27 on 04/24/24 | 130.13 on 04/19/24 |
| High | 23.21 on 03/07/24 | 153.59 on 04/25/24 | 13.41 on 04/23/24 | 241.00 on 04/24/24 | 145.00 on 04/23/24 |
| 1-Month | |||||
| %Chg | +3.00% since 02/08/24 | -8.61% since 03/25/24 | -7.63% since 03/25/24 | -3.40% since 03/25/24 | -1.78% since 03/25/24 |
| Low | 22.32 on 02/09/24 | 144.80 on 04/22/24 | 13.05 on 04/25/24 | 221.53 on 04/01/24 | 130.13 on 04/19/24 |
| High | 23.21 on 03/07/24 | 171.14 on 03/28/24 | 14.45 on 03/26/24 | 250.89 on 03/26/24 | 145.00 on 04/23/24 |
| 3-Month | |||||
| %Chg | +157.38% since 12/08/23 | -18.13% since 01/25/24 | -10.66% since 01/25/24 | +7.58% since 01/25/24 | -2.30% since 01/25/24 |
| Low | 8.44 on 12/12/23 | 144.80 on 04/22/24 | 13.05 on 04/25/24 | 208.62 on 02/08/24 | 128.00 on 02/07/24 |
| High | 23.21 on 03/07/24 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 250.89 on 03/26/24 | 148.37 on 03/21/24 |
| 6-Month | |||||
| %Chg | +195.00% since 09/08/23 | -6.30% since 10/25/23 | -9.86% since 10/25/23 | +5.10% since 10/25/23 | +27.28% since 10/25/23 |
| Low | 3.11 on 10/12/23 | 144.80 on 04/22/24 | 13.05 on 04/25/24 | 208.62 on 02/08/24 | 103.63 on 11/10/23 |
| High | 23.21 on 03/07/24 | 201.92 on 12/14/23 | 15.07 on 01/12/24 | 258.31 on 12/14/23 | 148.37 on 03/21/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 389,605 | 69,006,328 | 41,870,544 | 11,152,981 | 13,828,489 |
| Shares Outstanding, K | 16,932 | 457,359 | 3,164,818 | 47,059 | 99,507 |
| Annual Sales | 31,920,000 | 8,544,000,000 | 29,803,340,000 | 2,327,500,000 | 1,887,100,000 |
| Annual Net Income | -67,730,000 | 2,344,000,000 | 2,345,930,000 | 984,800,000 | 249,700,000 |
| Last Quarter Sales | 4,450,000 | 2,213,000,000 | 7,556,070,000 | 614,700,000 | 515,200,000 |
| Last Quarter Net Income | -1,800,000 | 525,000,000 | 718,900,000 | 217,100,000 | 147,700,000 |
| 60-Month Beta | 2.11 | 0.85 | 0.53 | 0.52 | 0.25 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.46 on 11/09/23 | 1.24 on 02/13/24 | 0.51 on 02/01/24 | 4.36 on 02/21/24 | 1.44 on 02/07/24 |
| Latest Earnings Date | 03/25/24 | 05/02/24 | 05/09/24 | 05/01/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.432 on 04/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 04/18/24 | 09/28/23 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 28.11 | 6.86 | 11.82 | 57.89 |